Report cover image

Transcatheter Aortic Valve Replacement (TAVR) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Publisher GlobalData
Published Aug 26, 2024
Length 200 Pages
SKU # GBDT19176692

Description

Transcatheter Aortic Valve Replacement (TAVR) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


Summary

GlobalData's Medical Devices sector report, “Transcatheter Aortic Valve Replacement (TAVR) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Transcatheter Aortic Valve Replacement (TAVR) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Transcatheter Aortic Valve Replacement (TAVR), also known as, Transcatheter Aortic Valve Implantation (TAVI), is a minimally invasive procedure used to treat severe aortic valve stenosis by implanting a Transcatheter Heart Valve in a patient's diseased aortic valve. The procedure is largely performed transfemorally (through the groin) but can also be performed via alternative pathways including the transapical, transaortic, transcarotid, transsubclavian and transcaval approaches.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Transcatheter Aortic Valve Replacement (TAVR) under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Transcatheter Aortic Valve Replacement (TAVR) and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Transcatheter Aortic Valve Replacement (TAVR) under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

200 Pages
    • Transcatheter Aortic Valve Replacement (TAVR) Overview
    • Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Stage of Development
    • Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Territory
    • Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Regulatory Path
    • Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Estimated Approval Date
    • Transcatheter Aortic Valve Replacement (TAVR) - Ongoing Clinical Trials
    • Transcatheter Aortic Valve Replacement (TAVR) Companies - Pipeline Products by Stage of Development
    • Transcatheter Aortic Valve Replacement (TAVR) - Pipeline Products by Stage of Development
    • Aegis Surgical Limited Company Overview
    • Anteris Technologies Ltd Company Overview
    • AorTx, Inc. Company Overview
    • Arbor Surgical Technologies, Inc. Company Overview
    • Atlas Medical Company Overview
    • Beijing Balance Medical Technology Co Ltd Company Overview
    • Biotronik AG Company Overview
    • Boston Scientific Corp Company Overview
    • Carena Healthcare Ltd Company Overview
    • Chengdu Silara Meditech Inc Company Overview
    • Colibri Heart Valve LLC Company Overview
    • ContiTech (Beijing) Medical Technology Co Ltd Company Overview
    • Daidalos Solutions BV Company Overview
    • Direct Flow Medical Inc (Inactive) Company Overview
    • Dongguan Tiantianxiang Medical Technology Co Ltd Company Overview
    • DSM Dyneema BV Company Overview
    • Dura LLC Company Overview
    • Edwards Lifesciences Corp Company Overview
    • Endoluminal Technology Research LLC Company Overview
    • Florida International University Company Overview
    • Folda LLC Company Overview
    • Foldax Inc Company Overview
    • HLT, Inc. Company Overview
    • JC Medical, Inc. Company Overview
    • JenaValve Technology GmbH Company Overview
    • Jenscare Scientific Co Ltd Company Overview
    • Jinshi Biotechnology (Changshu) Co Ltd Company Overview
    • KOKA Lifesciences Co Ltd Company Overview
    • Laguna Tech USA Inc Company Overview
    • Lepu Medical Technology (Beijing) Co Ltd Company Overview
    • Mayo Clinic Company Overview
    • Medtronic Plc Company Overview
    • Meril Life Sciences Pvt Ltd Company Overview
    • MicroPort CardioFlow Medtech Corp Company Overview
    • Nanjing Saint Medical Technology Co Ltd Company Overview
    • NewMed Medical Co Ltd Company Overview
    • Novogate Medical Ltd. Company Overview
    • NVT GmbH Company Overview
    • P+F Products + Features GmbH Company Overview
    • Peca Labs Inc Company Overview
    • Peijia Medical Ltd Company Overview
    • PolyNova Cardiovascular Inc Company Overview
    • RegenaGraft Company Overview
    • ReValve Med Inc Company Overview
    • SAS Cormove Company Overview
    • Shanghai Healing Medical Instruments Co Ltd Company Overview
    • St. Jude Medical LLC Company Overview
    • Stony Brook University Company Overview
    • Strait Access Technologies (Pty) Ltd Company Overview
    • Suzhou Jiecheng Medical Technology Co Ltd Company Overview
    • Symetis SA Company Overview
    • The University of British Columbia Company Overview
    • Thubrikar Aortic Valve, Inc. Company Overview
    • University College London Company Overview
    • University of California San Francisco Company Overview
    • University of Cambridge Company Overview
    • University of Iowa Company Overview
    • University of Pennsylvania Company Overview
    • Valve Medical Ltd. Company Overview
    • Vascular Concepts Ltd Company Overview
    • Venus Medtech Hangzhou Inc Company Overview
    • Xeltis AG Company Overview
    • Youngheartvalve LLC Company Overview
    • Aug 09, 2024: No Evidence to Support the Variation in Price the NHS Is Paying for Valves Used in Keyhole Heart Procedures
    • Jul 01, 2024: Anteris Technologies and v2vmedtech Announce Concept Lock of Next Generation Mitral and Tricuspid Repair System as VClip Passes Animal Study
    • Jun 24, 2024: The Landmark RCT marks a milestone for Meril's Myval THV series
    • Jun 18, 2024: Anteris Provides Update on Pivotal Trial Submission US FDA has provided positive eedback on key elements of the study design
    • Jun 17, 2024: CardioFlow's VitaFlow Liberty Granted EU CE-MDR Mark, Advancing Global Expansion Roadmap
    • Jun 13, 2024: Anteris Provides Update on DurAVR THV Valve-In-Valve Experience Presented at New York Valves 2024
    • Jun 13, 2024: Medtronic Confirms Global Layoffs
    • Jun 11, 2024: Anteris Provides Data Update on First in Human Study of DurAVR THV Presented at New York Valves 2024
    • Jun 07, 2024: New Data for Medtronic CoreValve/Evolut TAVR Systems Reinforces Excellent Valve Performance
    • Jun 06, 2024: MiRus Siegel TAVR: First in Human Results Presented at New York Valves
    • Jun 05, 2024: Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
    • May 22, 2024: MicroPort Donates Medical Devices for El Salvador's First TAVI in a Public Hospital
    • May 08, 2024: Edwards Launches the SAPIEN 3 Ultra RESILIA Valve in Europe with Technology to Enhance Durability
    • May 06, 2024: Thubrikar Aortic Valve Announces Clinical Success of the New Precision 2 Delivery Catheter
    • Apr 18, 2024: Siriraj Hospital Shines Spotlight on TAVI Procedure as Alternative for High-Risk Patients Requiring Aortic Valve Replacement
    • Apr 17, 2024: International Study Compares Self-Expanding and Balloon-Expandable Transcatheter Aortic-Valve Replacement in Patients with Small Aortic Annulus
    • Apr 07, 2024: SMART Trial One-Year Data Demonstrates Medtronic Evolut TAVR Platform as Optimal Treatment for Severe Aortic Stenosis in Patients with Small Annulus, which Is Primarily Women
    • Apr 07, 2024: Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
    • Apr 06, 2024: egnite and JenaValve Announce Novel Research on Outcomes with Untreated Aortic Regurgitation at the 2024 American College of Cardiology Conference
    • Mar 28, 2024: JenaValve Announces Publication of ALIGN-AR Pivotal Trial Results in The Lancet
    • Mar 27, 2024: Medtronic Announces FDA Approval of Newest-Generation Evolut TAVR System for Treatment of Symptomatic Severe Aortic Stenosis
    • Mar 19, 2024: Jenavalve's Trilogy THV System Highlighted at CRT 2024
    • Mar 13, 2024: Edwards presents positive data from two valve studies at CRT 2024
    • Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
    • Mar 11, 2024: New late-breaking data from Medtronic Evolut Low Risk Trial Demonstrate Strong Clinical and Cost-Effectiveness Benefits of TAVR Platform
    • Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company
    • Feb 23, 2024: Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
    • Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering
    • Feb 13, 2024: Interventional Cardiology at Adventist Health Glendale Reaches Milestone with 500th TAVR Procedure
    • Feb 06, 2024: Genesis MedTech concludes US J-Valve study enrollment
    • Jan 29, 2024: Peijia Medical Announces Successful Completion of Patient Enrollment for Pivotal TaurusTrio Transcatheter Aortic Regurgitation Clinical Trial
    • Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
    • Jan 04, 2024: EISENHOWER HEALTH BECOMES FIRST EDWARDS BENCHMARK PROGRAM OBSERVATION SITE FOR TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR), BEGINS HOSTING TAVR TEAMS FROM ACROSS THE NATION
    • Jan 03, 2024: Laguna Tech USA Announces Site Record Number of Transcatheter Heart Valves Implanted at Single Center on Same Day in First-in-Human Clinical Trial
    • Dec 15, 2023: Thubrikar Aortic Valve Announces Authorization to Expand the TAVI-1 CE Mark Trial with the Precision 2 Delivery Catheter
    • Dec 04, 2023: Colibri's valve shows superior haemodynamics in pilot study
    • Nov 20, 2023: MicroPort CardioFlow Completes Five Pre-Market Implantations of VitaFlow Liberty in Denmark
    • Oct 27, 2023: Japan Lifeline Enters into Exclusive Distribution Agreement with Meril Life Sciences for Myval Octacor Transcatheter Heart Valve in Japan
    • Oct 24, 2023: JenaValve Announces Late-Breaking Data from the ALIGN-AR Pivotal Trial Meeting Safety and Efficacy Endpoints
    • Oct 24, 2023: Medtronic Evolut TAVRPlatform Outperforms Surgery With Sustained Valve Performance for Low-Risk Patients at Four Years
    • Oct 24, 2023: Five-Year Data From Partner 3 Trial Demonstrate Excellent Survival for Patients Receiving Edwards Sapien 3 Valve
    • Oct 18, 2023: Edwards Lifesciences to Host Earnings Conference Call on October 25, 2023
    • Oct 12, 2023: Medtronic Receives CE Mark for Evolut FX TAVI System for Treatment of Severe Aortic Stenosis
    • Sep 19, 2023: JenaValve Announces ALIGN-AR Pivotal Data to be Presented During the Late-Breaking Clinical Trial Sessions at TCT 2023
    • Sep 11, 2023: Multiple MicroPort Business Groups Make an Appearance at SOLACI-SBHCI 2023
    • Aug 28, 2023: Edwards Lifesciences to Present at the 2023 Wells Fargo Healthcare Conference
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.